European Archives - Page 425 of 1612 - European Medical Journal

Stephen Freedland

Onc Now: Episode 22: Prostate Cancer, Lifestyle, and Equity

Stephen Freedland explores how lifestyle, equity, and emerging therapeutics are reshaping prostate cancer care, from risk to survivorship.

Global Obesity Prevalence Drops Under New Clinical Criteria, Study Finds

New obesity criteria would slash global prevalence rates, raising concerns for early detection and prevention in clinical care.

AI Helps Reduce High-Risk Antibiotic Use in Hospitals

A study of AI-guided infection prevention in hospitals found no drop in C. difficile rates but did see reduced use of risky antibiotics, especially in high-risk patients.

Atopic Dermatitis Severity Predicted by Flare Patterns

The study examined flare patterns reported in 2022 and correlated them with patient-reported severity measures recorded in 2023.

Infection Risk in Focus: How Do Haematologic Malignancies and Treatments Increase Infection Susceptibility?

Patients with hematologic malignancies are at increased risk of infections, driven by both disease-related immune dysfunction and the…

Heart Disease Mortality Falls as Other Cardiac Deaths Climb in US Study

US heart deaths have dropped since 1970, but deaths from heart failure and arrhythmias are on the rise.

Gecko-Inspired Nanoparticles Revolutionise Bladder Cancer Treatment

A new study offers an innovative solution inspired by nature: soft dendritic particles (SDPs) that mimic the adhesive properties of gecko feet.

Dr Joana Reis, Bayer

Bayer's Dr Joana Reis on the promise of AI in breast cancer

Dr Joana Reis, Medical Affairs Breast Lead, Radiology, Bayer, explores some of the most significant challenges and opportunities in radiology today.

Complement Inhibitors Could Treat Lung Injury in Sickle Cell Disease

Acute chest syndrome (ACS), a life-threatening complication of sickle cell disease (SCD), may be driven by overactivation of the complement system, according to new research.

Diffusion MRI Predicts Breast Cancer Response Early in Chemotherapy

A recent prospective study has directly compared different diffusion MRI parameters over the course of NAC to assess their ability to predict pathologic complete response.